BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11877890)

  • 1. [Disorders of emotional control in schizophrenia and unilateral brain damage].
    Kucharska-Pietura K; Kopacz G
    Psychiatr Pol; 2001; 35(6):965-77. PubMed ID: 11877890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Emotional behavior in schizophrenia and one-sided brain damage. Cerebral hemispheric asymmetry. Part I].
    Kucharska-Pietura K; Hunca-Bednarska A
    Psychiatr Pol; 2002; 36(3):421-34. PubMed ID: 12149918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Perception of chimeric faces in schizophrenia and right hemispheric dysfunction].
    Kucharska-Pietura K
    Psychiatr Pol; 2001; 35(6):979-89. PubMed ID: 11877891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activation level and the mechanism of emotional control in patients with paranoid schizophrenia].
    Jakubik A; Dudziak R; Karpiuk J; Kobrzyńska E; Watras J
    Psychiatr Pol; 1990; 24(3):189-94. PubMed ID: 2084726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The perception of emotional chimeric faces in schizophrenia: further evidence of right hemisphere dysfunction.
    Kucharska-Pietura K; David AS; Dropko P; Klimkowski M
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Jun; 15(2):72-8. PubMed ID: 12050469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disordered emotional processing in schizophrenia and one-sided brain damage.
    Kucharska-Pietura K
    Prog Brain Res; 2006; 156():467-79. PubMed ID: 17015097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
    Huguelet P; Nicastro R; Zanello A
    Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Emotional behavior in schizophrenia and one-sided brain damage--expression and verbalization of emotions. Cerebral hemispheric asymmetry. Part II].
    Hunca-Bednarska A; Kucharska-Pietura K
    Psychiatr Pol; 2002; 36(3):435-48. PubMed ID: 12149919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Perfomance in WCST in patients with schizophrenia: influence of clinical variables in manual laterality].
    Gutiérrez Rojas L; Molero Santos P; Ortuño Sánchez-Pedreño F
    Actas Esp Psiquiatr; 2005; 33(3):173-9. PubMed ID: 15918085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurological soft signs in schizophrenic patients and their nonaffected siblings].
    Mechri A; Slama H; Bourdel MC; Chebel S; Mandhouj O; Krebs MO; Gaha L
    Encephale; 2008 Oct; 34(5):483-9. PubMed ID: 19068337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
    Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
    Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emotional processing in Parkinson's disease. A study using functional transcranial doppler sonography.
    Troisi E; Peppe A; Pierantozzi M; Matteis M; Vernieri F; Stanzione P; Silvestrini M; Caltagirone C
    J Neurol; 2002 Aug; 249(8):993-1000. PubMed ID: 12195443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An fMRI study of theory of mind in schizophrenic patients with "passivity" symptoms.
    Brüne M; Lissek S; Fuchs N; Witthaus H; Peters S; Nicolas V; Juckel G; Tegenthoff M
    Neuropsychologia; 2008; 46(7):1992-2001. PubMed ID: 18329671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological differences between paranoid and nonparanoid schizophrenia: part I. sensory-motor lateralization.
    Nasrallah HA; McCalley-Whitters M; Kuperman S
    J Clin Psychiatry; 1982 Aug; 43(8):305-6. PubMed ID: 7096270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left temporal perfusion associated with suspiciousness score on the Brief Psychiatric Rating Scale in schizophrenia.
    Kohno T; Shiga T; Kusumi I; Matsuyama T; Kageyama H; Katoh C; Koyama T; Tamaki N
    Psychiatry Res; 2006 Oct; 147(2-3):163-71. PubMed ID: 16959474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of motor dexterity in schizophrenia assessed by a novel finger movement test.
    Midorikawa A; Hashimoto R; Noguchi H; Saitoh O; Kunugi H; Nakamura K
    Psychiatry Res; 2008 Jun; 159(3):281-9. PubMed ID: 18448171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.